The mitral valve is a flap-like structure made of two leaflets – anterior leaflet and posterior leaflet, located between the left heart chambers. It functions like a one-way door for the blood to flow from the left atrium into the left ventricle, then further across the aortic valve into the aorta supplying down to the entire body.
Mitral valve disease occurs when the mitral valve does not function properly. Forms of the disease include regurgitation (leakage), when the mitral valve leaflets are not able to close tightly, causing blood to leak back from the left ventricle into the left atrium; and stenosis when the mitral valve leaflets thickened or become stiff and fuse together, narrowing the valve opening resulting in inadequate blood flow from the left atrium into the left ventricle.

Mitral valve disease has many causes. Some forms can be already present at birth (congenital heart defect), while more commonly seen forms are developed later in life or acquired. The most common cause of mitral valve stenosis is rheumatic heart disease, where an infection (rheumatic fever) causes the heart to become inflamed. Mitral valve regurgitation, on the other hand, can be caused by mitral valve prolapse (floppy valve), endocarditis (infection), heart attack, or autoimmune disease such as lupus disease.
If left untreated, mitral valve disease can lead to serious, life-threatening complications such as heart failure, irregular and often rapid heart rate, blood clots and stroke.
Some patients can be symptom-free for many years even with serious mitral valve problems. Otherwise, signs and symptoms of mitral valve disease include fatigue, decrease in effort tolerance, heart murmur, palpitation, irregular heartbeat, and shortness of breath even at rest.
When diagnosing mitral valve disease, a cardiologist will require a thorough medical history, detailed physical examination and if required, investigations may include:
Mitral valve disease treatment depends on the symptoms, the severity of the condition, and the progress of the disease. Options may include monitoring the condition with regular follow-up visits, medications for the symptoms and medical interventions.
Percutaneous intervention of the mitral valve is done in the cardiac catheterisation lab by the structural heart team. Commonly performed procedures include:
A diseased or damaged mitral valve eventually will need to be repaired or replaced, even if no symptoms are present. Surgery for mitral valve disease includes mitral valve repair and mitral valve replacement.
Mitral valve surgery is traditionally performed via median sternotomy, which is an incision through the middle of the chest bone. In selected cases, mitral valve surgery can be performed through a minimally invasive approach. The incision will be over at the side of the chest rather than through the middle chest bone.
In mitral valve repair procedures, commonly used techniques include:

In certain cases, when the mitral valve condition is not amenable to repair, the diseased mitral valve has to be replaced, that is, to change a new one. During mitral valve replacement, the original mitral valve tissue is removed, after which a new valve (using a mechanical valve or a tissue valve made from cow, pig or human heart tissue) will be implanted.
For a mechanical valve, the patient has to take a life-long strong blood thinner (warfarin) to prevent clots on the valve. They will need to take blood tests regularly to monitor the effect of the blood thinner and take precautions to prevent excessive bleeding. With good care, a mechanical valve can last a lifetime and does not usually wear out.
A tissue valve, on the other hand, does not need life-long warfarin, although the patient may require blood thinning for other conditions such as chronic atrial fibrillation (or irregular heartbeat). Tissue valve can break down over time, with wear and tear or calcium deposition. There may be a need for re-intervention after 10 to 15 years, in which case, another operation or percutaneous intervention may be needed.
Mitral valve disease is not an uncommon disease in Singapore. Patients with mitral valve disease need to work closely with their cardiologist and cardiac surgeons to manage their symptoms and prevent complications. With early diagnosis, proper treatment and management, and lifestyle changes, patients with mitral valve disease may still lead a normal life.
Article is contributed by Dr Zhu Ling, Associate Consultant, Department of Cardiothoracic Surgery at the National Heart Centre Singapore.
Original article from National Heart Centre Singapore.